Vaccinia Gangrenosa with Normal Humoral Antibodies A Case Possibly Due to Deficient Cellular Immunity Treated with N‐Methylisatin β‐Thiosemicarbazone (Compound 33T57, Marboran)
- 1 May 1966
- journal article
- Published by Wiley in Acta Paediatrica
- Vol. 55 (3) , 264-272
- https://doi.org/10.1111/j.1651-2227.1966.tb17653.x
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Tissue culture end-point titrations as a routine potency test for smallpox vaccineArchiv für die gesamte Virusforschung, 1964
- PROPHYLACTIC TREATMENT OF SMALLPOX CONTACTS WITH N-METHYLISATIN β-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN)The Lancet, 1963
- Vaccinia GangrenosaClinical Pediatrics, 1963
- VACCINIA GANGRENOSA DUE TO HYPOGAMMAGLOBULINÆMIAThe Lancet, 1963
- Drug for VacciniaBMJ, 1962
- Drug for VacciniaBMJ, 1962
- Case of Progressive VacciniaBMJ, 1958
- Vaccinia Gangrenosa and AgammaglobulinaemiaArchives of Disease in Childhood, 1957
- Vaccinia Gangrenosa: The Report of a Case of Prolonged Generalized VacciniaArchives of Disease in Childhood, 1952
- Efficacy of B.C.G. VaccinationBMJ, 1948